000294403 001__ 294403
000294403 005__ 20250210094928.0
000294403 0247_ $$2doi$$a10.1021/acsmedchemlett.4c00324
000294403 037__ $$aDKFZ-2024-02232
000294403 082__ $$a610
000294403 1001_ $$0P:(DE-He78)c8c77862236d6e9b311705b9ecdf0413$$aLiolios, Christos$$b0$$eFirst author
000294403 245__ $$aSynthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate Cancer
000294403 260__ $$aWashington, DC$$bACS$$c2024
000294403 3367_ $$2DRIVER$$aarticle
000294403 3367_ $$2DataCite$$aOutput Types/Journal article
000294403 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1739177334_28365$$xLetter
000294403 3367_ $$2BibTeX$$aARTICLE
000294403 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000294403 3367_ $$00$$2EndNote$$aJournal Article
000294403 500__ $$aACS Med. Chem. Lett. 2024, 15, 11, 1970–1978 / #EA:W630#
000294403 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000294403 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000294403 7001_ $$aBouziotis, Danai$$b1
000294403 7001_ $$00000-0002-2876-9925$$aSihver, Wiebke$$b2
000294403 7001_ $$0P:(DE-He78)3373acf5d3b93adfd9ea973cf2d218aa$$aSchäfer, Martin$$b3$$udkfz
000294403 7001_ $$00000-0002-2820-9338$$aLambrinidis, George$$b4
000294403 7001_ $$aSalvanou, Evangelia-Alexandra$$b5
000294403 7001_ $$0P:(DE-He78)033d979f00729281e709b85fe6cae972$$aBauder-Wüst, Ulrike$$b6$$udkfz
000294403 7001_ $$0P:(DE-He78)0f034e05cefb010f991ef8b96009d95c$$aBenesova, Martina$$b7$$udkfz
000294403 7001_ $$aKopka, Klaus$$b8
000294403 7001_ $$00000-0001-6110-1903$$aKolocouris, Antonios$$b9
000294403 7001_ $$00000-0001-6778-2201$$aBouziotis, Penelope$$b10
000294403 773__ $$0PERI:(DE-600)2532386-6$$a10.1021/acsmedchemlett.4c00324$$gp. acsmedchemlett.4c00324$$n11$$p1970–1978$$tACS medicinal chemistry letters$$v15$$x1948-5875$$y2024
000294403 909CO $$ooai:inrepo02.dkfz.de:294403$$pVDB
000294403 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c8c77862236d6e9b311705b9ecdf0413$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000294403 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3373acf5d3b93adfd9ea973cf2d218aa$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000294403 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)033d979f00729281e709b85fe6cae972$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000294403 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0f034e05cefb010f991ef8b96009d95c$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000294403 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000294403 9141_ $$y2024
000294403 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bACS MED CHEM LETT : 2022$$d2023-10-26
000294403 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-26
000294403 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-26
000294403 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-26
000294403 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-26
000294403 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-26
000294403 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-26
000294403 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-26
000294403 915__ $$0StatID:(DE-HGF)1200$$2StatID$$aDBCoverage$$bChemical Reactions$$d2023-10-26
000294403 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-26
000294403 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-26
000294403 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-26
000294403 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-26
000294403 9201_ $$0I:(DE-He78)W630-20160331$$kW630$$lRadiopharmazeutika und Präklinische Studien$$x0
000294403 9200_ $$0I:(DE-He78)W630-20160331$$kW630$$lRadiopharmazeutika und Präklinische Studien$$x0
000294403 980__ $$ajournal
000294403 980__ $$aVDB
000294403 980__ $$aI:(DE-He78)W630-20160331
000294403 980__ $$aUNRESTRICTED